Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Mid 2022 for filing and H2 2022 for the trail to commence I believe Wolfiebill
Company's plan to submit a CTA application in mid-2022 and to commence a Phase 1a clinical trial with SDC-1801 in H2 2022.
Hi all. Am I right in thinking that the initial CTA won’t have an indication attached to it as it’s still effectively a dosing exercise. Hence CTA phase 1a? Only after this will any indications be announced which at the earliest will be 2023. Forgive if I’m wrong but that’s what I understood from the RNS.
Thanks in advance.
Hi all. Please forgive my ignorance but what happens to the funds and SP if a licensing deal is done with an up front payment? Do the funds go into company coffers and the SP rises to a market value determined by the market for a company with a now larger, profit making string to its bow? Just wondering what happens if this is the route rather than complete T/O. Thanks in advance.
https://www.lse.co.uk/rns/SAR/us-patent-notice-of-allowance-for-sdc-1802-0n6b1f95ld8fbo1.html
It’s at the top of the chat page mate
Hi Stoney. I think it’s because people have been forced to register/login to access the boards. I’ve got nothing to add to the excellent information and research here so won’t be posting but thought I’d say why I think people are. Thanks to all who contribute here, you’ve been a wealth of information I have benefitted greatly from your work. Good luck and good day to all.